Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Yoshihiko Sano

Market Cap

167.66 Billion JPY

Sector

Healthcare

Website

https://www.nipro.co.jp

Description

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses.

Read More

Overview

Value

88

Growth

33

Health

45

Management

50

Analyst Opinion

71

Total

57

All Scores Out Of 100

Best Features

  • Has a history of share buybacks
  • Price-to-earnings ratio of 13.6 is lower than the market average (19.6x)
  • Has a margin-of-safety above fair value
  • Liked by analysts
  • Low preportion of income is paid as dividend

Risk Factors

  • Earnings have declined recently
  • Has a high level of debt
  • Poor earnings and cashflow growth
  • Very undervalued

Market Peers

8086.T

Key Figures

PE Ratio (TTM)

13.56

Margin Of Safety (DCF)

338.54%

Revenue Growth (5 Year Average)

7.84%

Ratings Consensus

Buy

Share Buybacks

0.48%

Dividend Yeild (TTM)

1.81%

Valuation

Value Score

88

  • Price-to-earnings ratio of 13.6 is lower than the market average (19.6x)
  • Free-cashflow-yeild of 12.96% is better than the market average (4.7%)
  • Margin-of-safety of 338.54% is better than the market average (17.95%)
  • Estimated intrinsic-value of 4.52 Thousand JPY is higher than current price ( 1.03 Thousand JPY)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 4731.4 JPY

Current Price: 1031 JPY

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

13.56x

Free Cashflow Yeild

12.96%

PE/Earnings Growth

N/A

Price/Book

0.71x

Growth

Growth Score

33

  • Revenue growth has improved this yeara
  • 5 Year Average Revenue growth of 7.84% is lower than the market average (10.97%)
  • 5 Year Average Earnings growth of 3.56% is lower than the market average (14.48%)
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of 3.21% is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

7.84%

Earnings Growth

3.56%

Cashflow Growth

3.21%

Health

Health Score

45

  • Assets cover liabilities
  • Has a high level of debt
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

1.03

Piostroski Score

6.00

Debt/Equity

3.05x

Current Assets/Liabilities

1.40x

Free Cashflow/Total Debt

0.12x

Debt/Capital

1.29x

Dividend

Secure Dividend Score

53

  • Dividend is likely safe
  • Long term dividend payout ratio of 23.33% is considered good
  • Payout ratio (TTM) of 24.49% is lower than the average (40%)
  • Dividend growth has been accelerating recently
  • Dividend yeild of 1.81% is less than the market average (1.85%)
  • Dividends have been declining over the last 5 years
  • Spending a higher percentage of their income on dividends than last 5 years

Dividend Yeild

1.81%

Dividend Growth

25.05%

Payout Ratio (Earnings)

24.49%

Payout Ratio (Cashflow)

13.94%

Management

Management Score

50

  • Has repurchased shares when value is good
  • Has a history of returning value to shareholders through stock buybacks
  • Return-on-capital-employed of 9.51% is lower than the market average (10%)
  • Return-on-equity of 7.26% is lower than the market average (15%)

Average Buybacks/Dilution

0.48%

Recent Buybacks/Dilution

-0.00%

5 Year Price Volitility

12.82%

Return On Assets

1.45%

Return On Capital Employed

9.51%

Return On Equity

7.26%

Return On Free Cashflow

20.36%

Return On Investments

29.89%

Analysts

Analyst Opinion

71

  • Ratings consensus is Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Nipro Corporation

Currency

JPY

Beta

0.312671

Vol Avg

398378

Ceo

Mr. Yoshihiko Sano

Cik

Cusip

Exchange

Tokyo

Full Time Employees

36259

Industry

Medical Instruments & Supplies

Sector

Healthcare

Ipo Date

2001-01-01

Address

3-9-3 Honjo-nishi

City

Osaka

State

Country

JP

Zip

531-8510

Phone

81 6 6372 2331

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies